Integrated multi-sample transcriptomic analysis of COVID-19 patients against controls using a bioinformatics pipeline

利用生物信息学流程对 COVID-19 患者和对照组进行多样本转录组整合分析

阅读:1

Abstract

Prior coronavirus disease 2019 (COVID-19) transcriptomic studies using diverse methods for differential gene expression (DGE) profiling of specific samples yielded inconsistent results. To validate the shared molecular patterns of COVID-19 across cell, tissue, and systemic levels, we conducted a systematic rank combination meta-analysis of differentially expressed gene (DEG) profiles sourced from various sample types using a standardised bioinformatics pipeline consisting of DESeq2, RankProd, and weighted gene correlation network analysis (WGCNA). Consistently upregulated ISGs (including key hub gene IFIT2), compared with interleukins were identified in swab samples, reflecting dominant innate immune responses at the viral entry point. Blood samples revealed diverse gene functions in immune and neurological regulation, highlighting the complex interplay of systemic regulation. Significant enrichment of immunoglobulin-related and extracellular matrix genes indicates their role in the host adaptive immunity and long-term host responses in tissue samples. Novel key hub genes in tissue samples, GPD1 and CYP4A11 related to metabolic dysregulation were identified, potentially contributing to the severity of the disease. These findings portray the molecular basis of COVID-19 progression from localised innate responses to systemic effects and finally tissue-specific adaptive immunity and remodelling, providing insights that may inform diagnostic and therapeutic development.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。